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Dear participants, dear colleagues, 
 
It is our great pleasure to welcome you to the 65th Annual Meeting of the German Society of Neuropathology 
and Neuroanatomy - the brain and nerve microenvironment in health and disease - which will be held as a virtual 
meeting from September 1–3, 2021. 
The meeting will bring together basic and clinical researchers, physicians as well as junior scientists and PhD 
students from different disciplines of basic and clinical neuroscience. We will have outstanding lectures by and 
with some of the most renowned international experts in the field of neuro-oncology, neuroinflammation, neu-
rodegeneration and muscle and nerve diseases and look forward to exciting scientific discussions. There will also 
be a special and timely section on the effects of COVID-19 on the central and peripheral nervous system. 
The three days will offer exciting insights into different areas of basic and clinical neuroscience. We have also 
encouraged early career scientists to present their scientific findings in short talks and poster presentations. We 
are therefore particularly thankful that the abstracts of the meeting, which in their sum provide the best over-
view of the high scientific standing of the field, will be published in Free Neuropathology. 
Finally, we would like to thank you all for your active contribution to this conference in these difficult times. We 
also thank all supporters for their financial help. 
We wish you a stimulating and exciting conference.  
 
Yours sincerely, 
Prof. Dr. med. Till Acker 
Conference Chair (Justus Liebig University Giessen)  
PD. Dr. med. Anne Schänzer   Dr. med. Hildegard Dohmen 
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Microbiota-derived acetate enables the metabolic fitness of the 
CNS innate immune system during health and disease 
D. Erny1 
1 Institut für Neuropathologie, Neurozentrum, Freiburg i. Br., Germany 
Introduction: As tissue macrophages of the central nervous system (CNS) microglia constitute the pivotal im-
mune cells of this organ. Microglial features are strongly dependent on environmental cues such as commensal 
microbiota. Gut bacteria are known to continuously modulate microglia maturation and function by the produc-
tion of short-chain fatty acids (SCFA). However, the precise mechanism of this crosstalk is unknown. 
Objectives & Results: Here we determined that the immature phenotype of microglia from germ-free (GF) mice 
is epigenetically imprinted by H3K4me3 and H3K9ac on metabolic genes associated with substantial functional 
alterations including increased mitochondrial mass and specific respiratory chain dysfunctions. We identified 
acetate as the essential microbiome-derived SCFA driving microglia maturation and regulating the homeostatic 
metabolic state, and further showed that it is able to modulate microglial phagocytosis and disease progression 
during neurodegeneration. 
Conclusion: These findings indicate that acetate is an essential bacteria-derived molecule driving metabolic path-
ways and functions of microglia during health and perturbation. 
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Multiple sclerosis immunopathological patterns and their MRI 
correlates 
I. Metz1, R. Gavrilova2, S. Weigand3, Y. Guo2, N. Zalewski2, M. Gloth1, O. Tobin2, H. Lassmann4, J. Tillema2, 
B. Erickson2, J. Parisi5, B. Popescu6, S. Becker7, F. König8, J. Frischer9, W. Brück1, C. Lucchinetti2 
1 University Medical Center Göttingen, Georg-August-University, Institute of Neuropathology, Göttingen, Germany 
2 Mayo Clinic, Department of Neurology, Rochester, NY, United States 
3 Mayo Clinic, Department of Health Sciences Research, Rochester, NY, United States 
4  Medical University Vienna, Department of Neuroimmunology, Center for Brain Research, Vienna, Austria 
5 Mayo Clinic, Department of Laboratory Medicine and Pathology, Rochester, NY, United States 
6  University of Saskatchewan, Department of Anatomy, Physiology and Pharmacology, and Cameco MS Neuro-
science Research Center, Saskatchewan, Canada 
7 University Medical Center Göttingen, Department of Palliative Medicine, Göttingen, Germany 
8  Klinikum Kassel, Institute of Pathology, Kassel, Germany 
9 Medical University Vienna, Department of Neurosurgery, Vienna, Austria 
 
Introduction: Early active multiple sclerosis lesions can be classified into three main immunopathological pat-
terns of active demyelination (patterns I-III) by histology. These patterns are inter-individually heterogeneous 
but intra-individually stable. In pattern I and II, a T-cell- and macrophage-associated demyelination is suggested, 
with pattern II only showing signs of a humoral immune response. Pattern III is characterized by inflammatory 
lesions with an oligodendrocyte degeneration. Patterns suggest pathogenic heterogeneity, and we postulated 
that they have distinct MRI correlates that may serve as biomarkers. 
Objectives: To analyze the MRI correlates of multiple sclerosis immunopathological patterns. 
Patients and Methods: We evaluated in an international collaborative retrospective cohort study the MRI lesion 
characteristics of 789 pre-biopsy and follow-up MRIs in relation to their histopathologically classified immun-
pathological patterns (n=161 subjects) and lesion edge features (n=112). 
Results: A strong association of a ring-like enhancement and a hypointense T2-weighted rim (T2w rim) with pat-
tern I and II, but not pattern III, was observed. Only a fraction of pattern III patients showed a ring-like enhance-
ment, and this was always atypical. Ring-like enhancement and T2w rims colocalized, and ring-like enhancement 
showed a strong association with macrophage rims as shown by histology. A strong concordance of MRI lesion 
characteristics, meaning that different lesions showed the same features, was found, indicating lesion homoge-
neity within individual patients.  
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Conclusion: We provide robust evidence that MRI characteristics reflect specific histological features of MS im-
munopatterns and that ring-like enhancement and T2w hypointense rims might serve as a valuable non-invasive 
biomarker to differentiate pathological patterns of demyelination.  
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Microvascular vulnerability to cytokine toxicity is a critical initiat-
ing factor in cerebral interferonopathies 
B. Viengkhou1, E. Hayashida1, S. McGlasson2, K. Emelianova2, Y. Crow2, A. Pagenstecher3, D. Hunt2, M. 
Hofer1 
1 The University of Sydney, Charles Perkins Centre, Sydney, Australia 
2 The University of Edinburgh, Edinburgh, United Kingdom 
3 University of Marburg, Dept. Neuropathology, Marburg, Germany 
Cerebral interferonopathies are a group of devastating diseases characterised by overproduction of interferon-
alpha (IFN-α), leading to diffuse brain damage. Importantly, the critical cellular mediators of IFN-α are unknown. 
Here we use a mouse model of brain-targeted IFN-α production to identify endothelial cells as the major media-
tor of IFN-α neurotoxicity. Specifically, we have created a single cell atlas of the "cerebral interferome" using 
single cell RNA sequencing of brain cells of wild type and IFN-α transgenic mice. By linking this dataset with neu-
ropathological studies of cerebral interferon overproduction, we identified a role for cerebral endothelial cells in 
the initiation of brain disease. We then confirmed a critical role for endothelial interferon signalling through 
targeted deletion of the type I interferon receptor IFNAR on endothelial cells of the transgenic mice. Remarkably, 
this intervention led to near-complete rescue of the complex multicellular disease phenotype. Importantly, we 
show that diffuse aspects of interferonopathic brain disease such as calcification and neuronal loss arise as a 
downstream consequence of cytokine-induced microvascular disease. 
In conclusion, our data identify damage to the cerebral microvasculature as the critical first step in interferon 
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Neurooncology Adult I (from Mechanisms to Translation)  
NOA-01 
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Molecular mechanism of therapy resistance in malignant mela-
noma brain metastasis 
E. Schumann1, R. Koll1, J. Onken2, K. Jürchott3, T. Redmer4, J. Radke1 
1 Charité – Universitätsmedizin Berlin, Department of Neuropathology, Berlin, Germany 
2 Charité – Universitätsmedizin Berlin, Department of Neurosurgery, Berlin, Germany 
3 Charité – Universitätsmedizin Berlin, Institute of Medical Immunology, Berlin, Germany 
4 University of Veterinary Medicine Vienna, Department of Medical Biochemistry, Vienna, Austria 
Introduction: Malignant melanoma (MM) has the highest potential to disseminate to the CNS. About 45% of 
patients suffer from brain metastasis, which likely proceed continuously during the course of disease. Genetically 
and molecularly distinct subclones lead to tumor heterogeneity, therapy resistance and poor prognosis. Previous 
studies suggested increased metastatic spread to and within the brain during BRAF inhibitor (BRAFi) therapy, 
which is caused by upregulation of a subset of molecular drivers that control migratory and invasion such as the 
nerve growth factor receptor CD271/NGFR. 
Objectives: To investigate the molecular features of migration and invasion of patient derived cell lines from MM 
brain metastases (BM) that were therapy-responsive or therapy-resistant to BRAFi, radiotherapy and immune 
checkpoint inhibitors. 
Patients & Methods: We isolated and cultured patient derived cell lines from MM BM (n = 9) and DNA-sequenc-
ing (n = 5) and transcriptome analyses (n = 2) of cell lines and concordant tumor (n = 2).  The Incucyte® Live-Cell 
Analysis was used to perform high throughput scratch wound assays with patient derived cell lines, which were 
genetically modified to overexpress or downregulate the expression of NGFR. 
Results: Transcriptome profiling of BRAFi resistant MM BM revealed that the invasive potential increased during 
disease progression, which was accompanied by upregulation of NGFR expression. This phenotype was preserved 
in patient derived cells lines, which demonstrated significantly higher potential of two-dimensional in vitro mi-
gration (90% vs. 76% after 100 hours). Furthermore, CD271 knockdown was associated with loss-of-expression 
of several genes involved in migration and invasion such as ERBB3, TCF19 and BAALC. 
Conclusion: Brain metastases are the major cause of death in metastasized MM. Our study provides a longitudi-
nal perspective on the progression of brain metastasis and their mechanisms leading to therapy resistance.  
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Molecular characterization of sporadic endolymphatic sac tu-
mours and comparison to von Hippel-Lindau disease-related tu-
mours 
L. Schweizer1, F. Thierfelder1, C. Thomas2, P. Soschinski2, H. Y. Kim1, R. Jödicke1, N. Woltering2, A. Förster1, 
D. Teichmann1, C. Siewert1, K. Klein1, S. Schmid1, M. Nunninger3, U. W. Thomale4, J. Onken5, H. 
Mühleisen6, J. Schittenhelm7, M. Tatagiba8, A. von Deimling9, D. E. Reuss9, D. A. Solomon10, F. L. Heppner1, 
A. Koch1, C. Hartmann11, O. Staszewski12, D. Capper1 
1 Charité – Universitätsmedizin Berlin, Department of Neuropathology, Berlin, Germany 
2 University Hospital Münster, Department of Neuropathology, Münster, Germany 
3 Charité – Universitätsmedizin Berlin, Department of Radiology, Berlin, Germany 
4 Charité – Universitätsmedizin Berlin, Department of Neurosurgery, Division Pediatric Neurosurgery, Berlin, Ger-
many 
5 Charité – Universitätsmedizin Berlin, Department of Neurosurgery, Berlin, Germany 
6 SYNLAB Labor für Pathologie Mutlangen, Mutlangen, German 
7 Institute of Pathology and Neuropathology, University of Tübingen, Department of Neuropathology, Tübingen, 
Germany 
8 University Hospital Tübingen, Department of Neurosurgery, Tübingen, Germany 
9 Heidelberg University Hospital, Department of Neuropathology, Institute of Pathology, Heidelberg, Germany 
10 University of California, Division of Neuropathology, Department of Pathology, San Francisco, CA, United States 
11 Hannover Medical School (MHH), Department of Neuropathology, Hannover, Germany 
12 Faculty of Medicine, University of Freiburg, Institute of Neuropathology, Freiburg i. Br., Germany 
 
Introduction. Endolymphatic sac tumours (ELSTs) are low-grade tumours arising from the endolymphatic sac in 
the temporal bone. ELSTs can be locally aggressive and may even expand into the posterior fossa representing a 
rare differential diagnosis for tumours of the cerebellopontine angle. Although inactivation of the von Hippel-
Lindau gene (VHL) on chromosome 3p25 is considered to be the major cause of hereditary endolymphatic sac 
tumours (ELSTs), the genetic background of sporadic ELST is largely unknown.  
Objectives. The aim of this study was to determine the prevalence of VHL alterations in sporadic ELSTs and com-
pare their characteristics to VHL-disease-related tumours.  
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Materials and Methods. We analyzed 11 sporadic and 11 VHL-disease-related ELSTs by targeted sequencing and 
DNA methylation analysis.  
Results. VHL mutations and small deletions detected by targeted deep sequencing were identified in 9/11 spo-
radic ELSTs (82%). No other cancer-related genetic pathway was altered except for TERT promoter mutations in 
two sporadic and one VHL-disease-related ELSTs (15%). Loss of heterozygosity of chromosome 3 was found in 
6/10 (60%) VHL-disease-related and 10/11 (91%) sporadic ELSTs resulting in biallelic VHL inactivation in 8/10 
(73%) sporadic ELSTs. DNA methylation profiling did not reveal differences between sporadic and VHL-disease-
related ELSTs, but reliably distinguished ELST from morphological mimics of the cerebellopontine angle. VHL pa-
tients were significantly younger at disease onset compared to sporadic ELSTs (29 vs. 52 years, p < 0.0001, Fish-
er's exact test). VHL-disease status was not associated with an increased risk of recurrence, but the presence of 
clear cells was found to be associated with shorter progression-free survival (p = 0.0002, log-rank test).  
Conclusion. Biallelic inactivation of VHL is the main mechanism underlying ELSTs, but unknown mechanisms be-
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Establishment and characterization of a meningioma cell model 
with RagC knockout 
R. Diaz Peregrino1, J. Kahr1, N. Waldt1, E. Kirches1, C. Mawrin1 
1 Otto-von-Guericke Universität Magdeburg, Institut für Neuropathologie, Magdeburg, Germany 
Amino acid sensors are essential for cell growth and carcinogenesis via the mTORC1 pathway. IOMM Lee cells 
are suitable to study the meningioma pathogenesis, and amino acid sensors like RagC can be investigated in 
these cells. 
The aims of this work are (I) generate a meningioma cell line with RagC deficiency; (II) determine its morphology; 
(III) characterize it in vitro using cell viability assay, Trypan blue cell counting assay, colony formation assay, and 
BrdU assay; (IV) and measure its motion. 
RagC knockout was achieved through CRISPR-Cas9 system and corroborated by western blot. The area and cir-
cularity of IOMM RagCKO and IOMM Scr (scramble control) cells were determined by phalloidin staining. In vitro 
assays at 24 and 48 hours were performed to Scr and RagCKO cells cultured in normal and leucine-depleted 
medium. Wound healing assay, velocity, displacement, acceleration, and percentage of moving cells were meas-
ured in both cell lines seeded in the standard and leucine-free medium. 
Cell area was similar between cell genotypes, but RagCKO cells were more elongated than Scr cells. Based on cell 
genotype comparison, RagCKO cells were more metabolically active and displayed more cell proliferation than 
Scr cells. Centered on media comparison, cell numbers and cell proliferation decayed in both cell lines when 
cultivating them in the leucine-free medium. Only RagCKO cells had a reduction in ATP production under leucine 
withdrawal. Finally, RagCKO cells exhibited higher motility than Scr cells judged by the motion parameters. More-
over, the motility of RagCKO cells was resistant towards leucine depletion and even increased in comparison to 
Scr cells. 
RagCKO cells displayed increased proliferation and ATP production in leucine-supplied scenarios and accelerated 
migration under leucine-deprived conditions. Changes in AKT and pp70S6 signaling may be involved in both phe-
nomena. Furthermore, the morphological modifications of RagCKO cells might enhance their motion. 
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The role of 2-oxoglutarate homeostasis in tumour invasion and 
metastasis in glioblastoma  
A. Alserw1, N. Bögürcü-Seidel1, S. Seidel2, S. Gräf1, S. Zukunft3, I. Fleming3, S. Günther4, M. Looso4, A. 
Németh1, B. Garvalov1,5, T. Acker1 
1 Justus-Liebig-University Gießen, Institute for Neuropathology, Gießen, Germany 
2 Institute of Cell Biology and Neuroscience and Buchmann Institute for Molecular Life Sciences (BMLS), Goethe 
University, Frankfurt a. M., Germany 
3 Goethe University Frankfurt, Institute for Vascular Signalling, Frankfurt a. M., Germany 
4 Max Planck Institute for Heart and Lung Research, Bioinformatics Core Unit (M.L., P.G.), Bad Nauheim, Germany 
5 European Center for Angioscience (ECAS), Department of Microvascular Biology and Pathobiology, Mannheim, 
Germany 
 
Introduction: Metabolic reprogramming has been associated with tumour invasion and metastasis. Epithe-
lial/proneural-to-mesenchymal transition (EMT/PrMT) is a key process behind cancer cell dissemination, which 
is regulated by several transcription factors, including Snail. 2-oxoglutarate (2-OG) is a metabolite whose intra-
cellular level depends on the activity of isocitrate dehydrogenase 1 (IDH1). The metabolite acts as a co-substrate 
for 2-OG-dependent dioxygenases (2-OGDDs) which regulate different cellular activities. While mutant-IDH-in-
duced, 2-OGDD-dependent tumorigenic mechanisms have been described in detail, it is less well understood 
how wildtype IDH and 2-OG levels control EMT and invasion. 
Objectives: We aim to define the homeostatic function of IDH1 and 2-OG in the regulation of EMT and tumour 
progression primarily in glioblastoma, as well as in breast and lung cancer models. 
Materials and Methods: Boyden chamber, western blot, IF, RT-qPCR, RNAseq and metabolite MS assays are 
employed to determine the role of IDH1 and 2-OG levels on EMT regulators and cell invasion. IDH1 knockdown 
and several functional assays are used to further explore the underlying mechanisms. 
Results: We observed that TGFβ; an established EMT inducer results in IDH1 downregulation, with a concomitant 
increase in Snail expression and invasion. Strikingly, 2-OG supplementation reverts TGFβ induced Snail at the 
mRNA and protein level as well as cellular invasion in vitro. In line with a functional role of IDH1 in EMT, IDH1de-
ficiency promotes invasion and metastasis and enhances a cancer stem cell phenotype. Importantly, we identify 
HIF and mTOR signalling as two crucial mechanistic pathways involved in Snail regulation by 2-OG. 
Conclusion: Collectively, our findings emphasize the interplay between metabolism and metastasis and reveal 
novel mechanistic insights into the role of wildtype IDH and intracellular 2-OG levels in the metabolic control of 
tumor invasion and EMT/PrMT. 
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Infratentorial IDH-mutant astrocytoma is a distinct subtype 
R. Banan1, D. Stichel1, A. Bleck2, B. Hong3, U. Lehmann4, A. Suwala1, A. Reinhardt1, D. Schrimpf1, R. 
Buslei5, C. Stadelmann-Nessler6, K. Ehlert7, M. Prinz8, T. Acker9, J. Schittenhelm10, D. Kaul11, L. 
Schweizer12, D. Capper12, P. N. Harter13, N. Etminan14, D. T. W. Jones15, S. M. Pfister16, C. Herold-Mende17, 
W. Wick18, F. Sahm1, A. von Deimling1, C. Hartmann2, D. E. Reuss1 
1 Heidelberg University Hospital, Department of Neuropathology, Institute of Pathology, Heidelberg, Germany 
2 Hannover Medical School (MHH), Department of Neuropathology, Institute of Pathology, Hannover, Germany 
3 Hannover Medical School (MHH), Department of Neurosurgery, Hannover, Germany 
4 Hannover Medical School (MHH), Institute of Pathology, Hannover, Germany 
5 Klinikum Bamberg, Institute of Pathology, Bamberg, Germany 
6 University Medical Center Göttingen, Institute of Neuropathology, Göttingen, Germany 
7 University of Greifswald, Department of Pediatric Oncology and Hematology, Greifswald, Germany 
8 University of Freiburg, Institute of Neuropathology, Freiburg i. Br., Germany 
9 Institute of Neuropathology, University of Gießen, Gießen, Germany 
10 University Hospital Tübingen, Department of Neuropathology, Tübingen, Germany 
11 Charité – Universitätsmedizin Berlin, Department of Radiation Oncology and Radiotherapy, Berlin, Germany 
12 Charité – Universitätsmedizin Berlin, Department of Neuropathology, Berlin, Germany 
13 Goethe University Frankfurt, Institute of Neurology (Edinger Institute), Frankfurt a. M., Germany 
14 University Hospital Mannheim, University of Heidelberg, Department of Neurosurgery, Mannheim, Germany 
15 German Cancer Research Center (DKFZ), Pediatric Glioma Research Group, Heidelberg, Germany 
16 University Hospital Heidelberg, Department of Pediatric Oncology and Hematology, Heidelberg, Germany 
17 University Hospital Heidelberg, Department of Neurosurgery, Division of Experimental Neurosurgery, Heidelberg, 
Germany 
18 University of Heidelberg Medical Center, Neurology Clinic, Heidelberg, Germany 
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Introduction: Diffuse IDH-mutant astrocytic tumors are rarely diagnosed in infratentorial structures. Only few 
studies have reported single cases of infratentorial diffuse gliomas harboring IDH mutations, while suffering small 
case numbers. 
Objectives: In this multi-institutional study, we aimed to analyze infratentorial IDH-mutant astrocytomas in a 
larger series with respect to clinical and molecular parameters. 
Patients and methods: Tumor samples of patients with diffuse infratentorial astrocytomas from different Ger-
man neuropathology departments were investigated using immunohistochemistry, pyrosequencing, genome-
wide DNA methylation analysis and NGS panel sequencing. Overall survival data were assessed using Kaplan–
Meier method. 
Results: We identified a series of 43 infratentorial IDH-mutant astrocytomas from 42 patients. About 80% of IDH 
mutations were of non-IDH1-R132H variants which are rare in supratentorial astrocytomas. Most frequently, 
IDH1-R132C/G and IDH2-R172S/G mutations were present. Moreover, ATRX-loss and MGMT promoter methyl-
ation typically associated with IDH mutations in supratentorial astrocytomas, were significantly less frequent in 
the infratentorial compartment. Panel sequencing revealed two samples with IDH1-R132C/H3F3A-K27M co-mu-
tations. Methylation analysis and copy number profiling provided further evidence for a molecular distinctive-
ness of these tumors. Clinical outcome of patients with infratentorial IDH-mutant astrocytomas was significantly 
better than in patients with diffuse midline gliomas, H3K27M-mutant (p < 0.005) and poorer than in those with 
supratentorial IDH-mutant astrocytomas (p = 0.028). 
Conclusion: The presented data highlight the very existence and distinctiveness of infratentorial IDH-mutant as-
trocytomas implying that molecular testing is critical for detection of these tumors, since many of these tumors 
cannot be identified by immunohistochemistry applied for the mutated IDH1-R132H protein or loss of ATRX. 
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DNA methylation profiling and molecular grading of stereotaxic 
brain tumor biopsies 
K. Filipski1,2,3, J. Hench4, M. Armbrust1, P. S. Zeiner2,3,5, T. I. Hartung1, E. Steidl6, J. Quick-Weller7, T. 
Fenton8, J. P. Steinbach2,3,5, M. Czabanka7, D. Capper9,10, S. Frank4, K. H. Plate1,2,3, M. T. Forster7, P. N. 
Harter1,2,3 
1 University Hospital Frankfurt, Neurological Institute (Edinger Institute), Frankfurt a. M., Germany 
2 German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany 
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many 
 
Introduction: DNA methylation profiling of CNS tumors emerges as a powerful tool to support and refine histo-
logical diagnoses. Tumor entity-specific DNA methylation signatures allow for alignment with methylation classes 
and copy number profiling (CNP), the latter being of particular interest in terms of molecular grading regarding 
the upcoming WHO classification. When gross tumor resection is precluded, stereotaxic biopsies might not be 
representative of the bulk tumor, underlining the need for objective molecular diagnostic parameters.  
Objective: Here we investigated the diagnostic potential and accuracy of DNA methylation profiling and molec-
ular grading on small stereotaxic brain tumor biopsies.  
Materials & Methods: FFPE samples of 237 patients were subjected to DNA methylation analysis including the 
Heidelberg Brain Tumor Classifier, CNP and tumor deconvolution using MethylCIBERSORT.  
Results: Median DNA concentration was 6.26 ng/µl. 90.5% of STX samples (n=232) allocated to previously de-
fined DNA methylation classes, with 61.6% reaching classifier scores of > 0.84. Combined gain of chromosome 7 
and loss of chromosome 10 or EGFR amplification were detectable in 61% and 38% of IDH wildtype glioma 
(n=156), respectively. 64.5% of histological lower grade, IDH wildtype gliomas (n=31) were eligible for upgrading 
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to molecular glioblastoma. 58% of IDH mutant gliomas (n=31) presented with 1p/19q codeletion and 23% with 
homozygous deletion of CDKN2A/B. Recursive partitioning pointed at a minimum of 29.42% cancer cells for a 
0.83 probability to reach a matching calibrated score in glioblastoma, IDH wildtype. A DNA input threshold of 
3.53 ng/µl yielded matching DNA methylation classes with a probability of 0.69.  
Conclusion: Our findings demonstrate broad applicability of DNA methylation profiling and molecular grading to 
challengingly small, ill-defined brain tumor specimens with a special impact on grading of histologically lower 
grade, non-IDH mutant diffuse gliomas. 
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Prediction of meningioma methylation classes using AI-assisted 
digital histopathology 
J. Sehring1, H. Dohmen1, M. Manke1, D. Amsel1, A. Németh1, A. Mukhopadhyay2, T. Acker1 
1 Justus-Liebig-University Gießen, Institute of Neuropathology, Gießen, Germany 
2 Technical University Darmstadt, Medical and Environmental Computing, Darmstadt, Germany 
Introduction: Current studies suggest that DNA methylation-based molecular classification of meningioma has a 
higher predicting power for tumor recurrence than the current histology-based WHO classification. However 
DNA methylation profiling is costly, time-consuming and not widely available. Therefore, an AI-histology-based 
prediction of the six DNA methylation classes would be very beneficial and could additionally complement the 
molecular classification. Deep neural networks and their visual decoding power offer a promising tool to address 
this problem. 
Objectives: Our goal is to predict meningioma methylation classes using AI-assisted digital histopathology. 
Materials and methods: H&E stained histological slides were digitized with a Hamamatsu Nanozoomer S360 to 
obtain Whole Slide Images(WSI). Multiple image patches per patient were extracted and encoded into feature 
space using a pre-trained ResNet50. Those features were aggregated in a multiple instance learning setting using 
an attention network to predict the methylation class. 
Results: We have collected WSI data of 167 patients so far. Most specimens belong to the most frequently diag-
nosed methylation subgroups, namely benign-1 (n=36), benign-2 (n=55) and intermediate-A (n=60). Three sepa-
rate two-class classifications (benign-1 vs. benign-2, benign-1 vs. intermediate-A and benign-2 vs. intermediate-
A) are currently under development. Patients were allocated into training, validation and test sets (0.7/0.1/0.2) 
and we evaluated the patient-wise balanced accuracy on the test set in a 5-fold cross-validation. In addition, the 
attention weights for the image patches of a WSI were visualized for interpretability. 
Conclusion: We employ a framework for the prediction of methylation classes based on histological features. 
Visualization is used for an enhanced interpretability of the black-box network. This AI-framework may support, 
complement, and accelerate meningioma classification in the future. 
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In the spotlight: NK cell receptors in inclusion body myositis 
C. Nelke1, M. Pawlitzki2, T. Ruck1 
1 University Hospital Duesseldorf, Deparment for Neurology, Neurology, Düsseldorf, Germany 
2 University Hospital Münster, Department of Neurology with Intitute of Translational Neurology, Münster, Ger-
many 
 
Introduction: Inclusion body myositis (IBM) is the most common inflammatory idiopathic myopathy (IIM) of old 
age. As of yet, effective treatment approaches are lacking. A deeper immunological understanding is necessary 
to overcome this roadblock. As natural killer (NK) cells orchestrate the extent of inflammatory responses by cy-
tolytic properties in IIM capable of inducing bystander self-tissue damage, we aimed to characterize NK cell pat-
terns in IBM. 
Objectives: To determine NK cell patterns in IBM and identify drivers of NK cell activation. 
Patients & methods: We included 20 IBM patients and 20 age and sex matched non diseased controls (NDC). 
Peripheral blood was collected and peripheral blood mononuclear cells (PBMC) were isolated by density gradient 
centrifugation. Differences between groups were analyzed using unpaired Student"s t test or Mann–Whitney-U 
test as appropriate. Anti-cN-1A-antibodies were detected in patient serum using the EUROIMMUN immunoas-
say. 
Results: The activated CD56dim population was reduced in peripheral blood of IBM patients as compared to 
controls. Comparing surface expression as measured by mean fluorescence intensity, we observed a significant 
increase of NKG2A and NKG2D levels on the CD56dim NK cell subset in IBM patients as compared to NDC. Other 
surface receptors remained unchanged. Next, we were interested whether the antibody status of IBM patients 
affects expression of surface receptors. Consequently, comparison of anti-cN-1A positive and anti-cN-1A nega-
tive patients revealed that NKG2A level do not differ, while increased NKG2D levels were associated with anti-
cN-1A-ab positivity.  
Conclusion: Here, we report distinct NK cell patterns in IBM patients. Activated CD56dim NK cells are reduced in 
peripheral blood as compared to NDC. NKG2A and NKG2D levels are increased on CD56dim NK cells. Lastly, in-
creased NKG2D levels were associated with anti-cN-1-ab serostatus. 
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Mutations in BVES can lead to early onset of cardiac symptoms 
without clinical signs of muscle dystrophy in children and adoles-
cents 
A. Gangfuß1, A. Hentschel2, M. Gonzales3, A. Schönecker4, A. Töpf5, A. Sickmann2, A. Nishimura6, U. 
Schara-Schmidt1, A. Hahn7, A. Roos1, A. Schänzer6 
1 University Duisburg-Essen, Department of Pediatric Neurology, Centre for Neuromuscular Disorders, Centre for 
Translational Neuro- and Behavioral Sciences, Essen, Germany 
2 Leibniz-Institut für Analytische Wissenschaften - ISAS - e.V., Dortmund, Germany 
3 Justus-Liebig-University Gießen, Pediatric Heart Center, Gießen, Germany 
4 University Duisburg-Essen, Department of Pediatric Cardiology, Essen, Germany 
5 Newcastle University and Newcastle Hospitals NHS Foundation Trust, The John Walton Muscular Dystrophy Re-
search Centre, Translational and Clinical Research Institute, Newcastle upon Tyne, United Kingdom 
6 Justus-Liebig-University Gießen, Institute of Neuropathology, Gießen, Germany 
7 Justus-Liebig-University Gießen, Department of Child Neurology, Gießen, Germany 
 
Introduction: Limb-girdle muscular dystrophies occur in children and adults and may be associated with a high 
variability of the clinical phenotype. In some subtypes, cardiac involvement is the first and thus key symptom. 
Recently, Blood vessel endothelial substance (BVES), a gene encoding Popeye domain containing protein 1 
(POPDC1), has been implicated as a causative for limb-girdle dystrophy type R25 (LGMDR25), associated with 
cardiac arrhythmia and variable skeletal muscle involvement. Until today, only 10 adult patients with this rare 
autosomal recessive LGMD have been described. 
Objectives: With this study, we aim to broaden the phenotypic spectrum and improve the pathophysiological 
understanding of LGMDR25. 
Materials & methods: Hence, we describe the clinical phenotype of four affected children of two families with 
homozygous variants (c.457>T; p.Gln153Ter and c.578T>G, p.Ile193Ser) in Blood vessel endothelial substance 
(BVES). Additionally, we performed detailed muscle biopsy analysis from two affected patients including immu-
nofluorescence, electron microscopic and proteomic studies. 
Results: Highly elevated creatine kinase and cardiac involvement are present in all patients. Muscle weakness 
was not present in any of the patients, considering the oldest being 19 years old. However, histological and ul-
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trastructural analysis revealed a myopathy. Immunohistochemistry showed an absence of sarcolemnal expres-
sion of BVES confirming the diagnosis. Additional proteomic analyses were indicative for an impairment of the 
calcium balance and thus a potential influence on the contractile apparatus. 
Conclusion: To conclude, LGMDR25 should be considered in children with cardiac symptoms and highly elevated 
creatine kinase, even in the absence of muscle weakness. A muscle biopsy is helpful to confirm the diagnosis and 
to increase the understanding of the disease pathology. 
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Combining postmortem single cell analysis with an induced plu-
ripotent stem cell model to study dysregulated pathways in fron-
totemporal dementia 
O. Al Dalahmah1, R. Kühn1, T. Nguyen1, M. DeTure2, M. Siegelin1, D. Dickson2, J. P. Vonsattel1, J. Goldman1, 
P. Canoll1, G. Hargus1 
1 Columbia University, Department of Pathology and Cell Biology, New York, NY, United States 
2 Mayo Clinic, Jacksonville, FL, United States 
Introduction: Frontotemporal dementia (FTD) is a group of early-onset dementias leading to an impairment of 
behavior, language and cognition. FTD can be caused by mutations in the MAPT gene encoding the microtubule-
associated protein tau resulting in pronounced atrophy of the frontal and temporal lobes, basal ganglia and brain 
stem areas. 
Objectives: Currently, the underlying mechanisms of neurodegeneration are not clearly understood and curative 
options do not exit. 
Materials & Methods: Here, we performed single nucleus RNA sequencing (snRNA-seq) on postmortem brain 
tissue from FTD patients carrying the MAPTN279K mutation and from healthy control individuals to identify 
dysregulated pathways in patient cells at single cell resolution. 
Results: We found significant changes in pathways related to cell metabolism and neuroinflammation in patient 
neurons that we tested further in a stem cell model of FTD using patient- and control individual-derived induced 
pluripotent stem cells (iPSCs). Patient iPSC-derived neurons with the MAPTN279K mutation demonstrated tau 
pathology, an impairment of neurite outgrowth and an increased but reversible oxidative stress response. FTD 
neurons also showed altered metabolic profiles with an increased basal mitochondrial respiration and increased 
ATP production indicating an increased energy demand in these cells. Interestingly, FTD neurons also had a sig-
nificant effect on the survival of host neurons and on glial cell responses when transplanted into the brains of 
immunocompromised mice indicating a potential immunomodulatory role of patient neurons in vivo. 
Conclusion: These findings demonstrate that a combinatorial approach applying snRNA-seq on patient brain tis-
sue and a dynamic iPSC model comprises a powerful tool to identify disease phenotypes in neural cells at risk in 
FTD. Such stem cell model could also be used as a cellular platform for high-throughput drug screening assays to 
identify potential therapeutic targets in FTD. 
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Deep learning assisted quantitative assessment of histopatho-
logical markers of Alzheimer"s disease and cerebral amyloid an-
giopathy  
V. Perosa1,2, A. Scherleck3, M. Kozberg1, L. Smith4, T. Westerling-Bui4, C. A. Auger5, S. Vasylechko6, S. M. 
Greenberg1, S. J. van Veluw1,5 
1 Massachusetts General Hospital, 1J. Philip Kistler Stroke Research Center, Boston, MA, United States 
2 Otto-von-Guericke University, Department of Neurology, Magdeburg, Germany 
3 Rush University Medical Center, 3Rush Alzheimer Disease Center, Chicago, IL, United States 
4 Aiforia Inc, Cambridge, MA, United States 
5 Massachusetts General Hospital, MassGeneral Institute for Neurodegenerative Disease, Charlestown, MA, United 
States 
6 Boston Children's Hospital, Computational Radiology Laboratory, Boston, MA, United States 
Introduction: Traditionally, analysis of neuropathological markers in neurodegenerative diseases has relied on 
visual assessments of stained sections. Resulting semiquantitative scores often vary between individual raters 
and research centers, limiting statistical approaches. To overcome these issues, we have developed six deep 
learning-based models, that identify some of the most characteristic markers of Alzheimer"s disease (AD) and 
cerebral amyloid angiopathy (CAA). 
Methods: Deep learning-based models were trained to differentially detect parenchymal amyloid β (Aβ)-plaques, 
vascular Aβ-deposition, iron and calcium deposition, reactive astrocytes, microglia, as well as fibrin extravasa-
tion. The models were trained on digitized histopathological slides from brains of patients with AD and CAA, using 
a workflow that allows neuropathology experts to train convolutional neural networks (CNNs) on a cloud-based 
graphical interface. 
Results: Validation of all models indicated a very good to excellent performance compared to three independent 
expert human raters. Furthermore, the Aβ and iron models were consistent with previously acquired semiquan-
titative scores in the same dataset and allowed the use of more complex statistical approaches.  
Discussion: The presented workflow is easy for researchers with pathological expertise to implement and is cus-
tomizable for additional histopathological markers. The implementation of deep learning-assisted analyses of 
histopathological slides is likely to promote standardization of the assessment of neuropathological markers 
across research centers, which will allow specific pathophysiological questions in neurodegenerative disease to 
be addressed in a harmonized way and on a larger scale. 
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Exercise ameliorates Alzheimers pathology across generations 
A. Herring1, Y. Münster1, N. Kurapati1, R. Khadzhiev1, K. Keyvani1 
1 University Duisburg-Essen, Institute of Neuropathology, Essen, Germany 
Introduction: An active lifestyle reduces the risk of dementia and cognitive decline in Alzheimer"s diseases (AD) 
patients. Animal studies have shown that environmental enrichment increases the cognitive reserve and inter-
feres with the pathomechanisms of AD over a very extended period of ontogenesis, from in utero stimulation via 
maternal running during pregnancy until late exercise in a full-blown stage disease. 
Objectives: Here we asked whether protective effects of exercise against AD can be inherited across several 
generations and if so, what epigenetic modifications enable transgenerational transmission. 
Materials & methods: In the founder generation (F0), TgCRND8 mice (disease onset around postnatal day 90, 
P90) and wildtype littermates had either access to voluntary wheel running for six months, starting at P30, or 
were housed without exercise (control). From P90, either exercised mice were mated or mice that experienced 
a sedentary life style. The offspring was solely housed under control conditions and crossed until the third pro-
genitor generation. The progeny (F1-F3) was phenotyped for memory and explorative behaviour as well as amy-
loid beta (Aβ) pathology in an advanced stage disease (P210). To detect epigenetic transmitters, we determined 
the cerebral expression profile of microRNAs involved in Aβ metabolism. 
Results: We here show that great-grandparental running reduced Aβ plaque burden, enhanced cerebral levels 
of the Aβ efflux transporter MDR1 and further increased recognition memory and explorative behaviour in trans-
genic mice until the F3 generation. Further, the cerebral expression of microRNAs that promote Aβ pathology 
(miRNAs 342-3p, 16-5p, 9-5p) was strongly reduced following ancestral exercise. 
Conclusion: We conclude that protective effects of exercise can propagate across generations. Ongoing experi-
ments aim to decode further epigenetic modifications that enable transgenerational inheritance. 
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Co-activation of Sonic hedgehog and Wnt signaling in murine ret-
inal precursor cells drives ocular lesions resembling intraocular 
medulloepithelioma 
M. Dottermusch1,2, P. Sumislawski1, J. Krevet3,4, H. Voß5, M. Middelkamp1, H. Bartsch6, K. Sotlar6,7, A. 
Korshunov8, M. Glatzel1, U. Schüller1,4,9, J. Neumann1,2 
1 University Medical Center Hamburg-Eppendorf, Institute of Neuropathology, Hamburg, Germany 
2 University Medical Center Hamburg-Eppendorf, Center for Molecular Neurobiology (ZMNH), Hamburg, Germany 
3 Ludwig-Maximilians-University Munich, Center for Neuropathology, München, Germany 
4 Research Institute Children’s Cancer Center Hamburg, Hamburg, Germany 
5 University Medical Center Hamburg-Eppendorf, Institute of Clinical Chemistry and Laboratory Medicine, Ham-
burg, Germany 
6 Ludwig-Maximilians-University Munich, Department of Pathology, München, Germany 
7 Paracelsus Medical University, Department of Pathology, Salzburg, Austria 
8 German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Clinical Cooperation Unit Neuropa-
thology (G380), Heidelberg, Germany 
9 University Medical Center Hamburg-Eppendorf, Department of Pediatric Hematology and Oncology, Hamburg, 
Germany 
 
Introduction: Intraocular medulloepithelioma (IO-MEPL) is a rare embryonal ocular neoplasm, which prevalently 
occurs in young children and is commonly treated by enucleation of the eye. IO-MEPLs share common histomor-
phological features with variants of CNS embryonal tumors with multilayered rosettes (ETMR), referred to as 
intracranial medulloepitheliomas. While sonic hedgehog (Shh) and Wnt signaling pathways are crucial for ETMR 
pathogenesis, the impact of these pathways on human IO-MEPL development is unclear. 
Objectives: Our objective in this study was to explore the relevance of SHH and WNT signaling in human IO-
MEPLs and demonstrate the effect of simultaneous Shh and Wnt activation in mouse retinal precursor cells.  
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Materials & methods: Using Nanostring technology, gene expression data was obtained from FFPE tumor sam-
ples of 8 human IO-MEPLs, as well as 16 intracranial embryonal tumors comprising ETMRs, SHH-medulloblasto-
mas (MBs), WNT-MBs and Group 4-MBs. In order to unravel the function of Shh and Wnt signaling for IO-MEPL 
pathogenesis in vivo in a time point and cell specific manner, the tamoxifen inducible creERT2-lox system was 
utilized to activate Shh and Wnt signaling in Sox2- or Rax- expressing retinal precursor cells. 
Results: IO-MEPLs and ETMRs displayed similar gene expression patterns and significant simultaneous overrepre-
sentation of both SHH and WNT target genes.  Co-activation of both pathways in early Sox2- or Rax- expressing 
precursor cells resulted in infiltrative ocular lesions that displayed extraocular expansion. Histomorphological, 
immunohistochemical and molecular features of these lesions revealed strong concordance with those of human 
IO-MEPLs. 
Conclusion: We report a relevant role of WNT and SHH signaling in IO-MEPL and report a mouse model for this 
rare disease, setting the foundation for a targeted therapeutic approach with the aim of more commonly feasible 
eye salvage in affected patients. 
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Characterisation of spinal diffuse midline gliomas 
L. Stegat1, U. Schüller1,2,3, A. Wefers1 
1 University Medical Center Hamburg-Eppendorf, Institute of Neuropathology, Hamburg, Germany 
2 University Medical Center Hamburg-Eppendorf, Department of Pediatric Hematology and Oncology, Hamburg, 
Germany 
3 Research Institute Children’s Cancer Center Hamburg, Hamburg, Germany 
Introduction: Diffuse midline gliomas (DMGs) are malignant gliomas that grow in midline structures of the cen-
tral nervous system. Due to their aggressive and diffuse growth and a two-year survival rate of less than 10%, 
DMGs are graded as WHO grade IV. Depending on the localization, median age of patients is about 11-20 years. 
Genetically, tumors are defined by a K27M-mutation in one of the highly homologous genes encoding histone 
protein H3. While some studies state that the global DNA methylation pattern is correlated with the mutated 
histone gene, others suggest that it differs between DMGs of different localisations. 
Objectives: Since DMGs most frequently occur in pons and thalamus, comparatively little is known about spinal 
DMGs. Therefore, we histologically, molecularly and clinically characterised spinal DMGs and analysed in which 
aspects they differ from DMGs of other localizations as this may have diagnostical and/or clinical implications. 
Materials & methods: Our cohort currently consists of 17 spinal DMGs plus DMGs of different localisations. His-
tological and immunohistochemical analysis as well as molecular analyses (DNA methylation, DNA panel se-
quencing) were done from FFPE tissue. Clinical data were analysed with Prism. 
Results: Spinal DMGs were histologically very heterogeneous, both with regard to different areas of single tu-
mors as well as when comparing different tumors. Preliminary data suggest that there may be some differences 
to DMGs of different localisations, e.g. with regard to cell differentiation. First t-SNE analyses of DNA methylation 
data did not indicate a separation of spinal DMGs from those of different localisations. 10/11 spinal DMGs se-
quenced so far were H3F3A K27M-mutant, while one tumor had a HIST1H3B K27M mutation. Mean age was 22 
years. 
Conclusion: First analyses suggest slight histological differences of spinal DMGs compared to those of other lo-
calisations. Further histological, molecular and clinical analyses are ongoing. 
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Neurofilament light chains in serum are a biomarker for the acute 
axonal damage in MS lesions: A histological-serological correla-
tive study 
A. S. Beutler1, N. Kruse1, L. Stork1, M. Gloth1, C. Stadelmann-Nessler1, W. Brück1, I. Metz1 
1 University Medical Center Göttingen, Georg-August-University, Institute of Neuropathology, Göttingen, Germany 
Introduction: Multiple sclerosis (MS) is an inflammatory demyelinating disease of the CNS, associated with a 
variable axonal damage. The axonal damage is responsible for the irreversible clinical disability, and within the 
CNS no relevant neuroaxonal regeneration occurs. Thus, in MS patients it is of utmost importance to monitor 
and hinder the axonal damage from the earliest stages on. A promising biomarker are neurofilament light chains 
measured in serum (sNfL). However, sNfL do not provide any information regarding the localization of the neu-
roaxonal damage, and multiple factors influence sNfL levels. 
Objectives: To perform a histopathological-serological correlative study to show the pathological correlate of 
elevated sNfL levels in MS patients. 
Patients and Methods: 106 MS subjects with biopsy tissue and blood sample available were characterized for 
their acute axonal damage with the anti-APP staining and the chronic axonal damage with the Bielschowsky silver 
staining. Results were correlated with the neurofilament light chain levels in serum measured with the single 
molecular array (SiMoA) technique. 
Results: High sNfL levels were present in biopsied MS patients (median 59 pg/ml) compared to healthy controls 
(19 pg/ml), and levels were influenced by the age of patients, relapses prior blood sampling as well as the time 
interval after biopsy. Correlating histological parameters with sNfl, multiple regression analyses showed that the 
acute axonal damage within early active MS lesions significantly contributed to the sNfL (p<0.01), but not the 
axonal density. Importantly, sNfL correlated with the clinical disability at biopsy as well as at last follow-up. 
Conclusion: sNfL mirror the acute axonal damage in early MS lesions as shown by histology, and correlate with 
the clinical disability of patients. They are thus a promising biomarker to monitor the axonal damage ex vivo in 
MS patients. 
This study was sponsored by Novartis Pharma GmbH. 
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MGMT-promoter methylation in non-neoplastic diseases of the 
central nervous system 
S. Teuber-Hanselmann1, K. Worm2, A. Junker1 
1 Universitätsklinikum Essen, Institut für Neuropathologie, Essen, Germany 
2 Universitätsklinikum Essen, Institut für Pathologie, Essen, Germany 
Introduction: O6-methylguanine-DNA-methyltransferase (MGMT) plays a pivotal role in cellular defense by re-
pairing alkylated DNA. Hypermethylation of the MGMT promoter region results in gene silencing, an effect seen 
in various tumors, like gliomas. MGMT hypermethylation was postulated to be attributed to cancers or to malig-
nant transformation of precancerous lesions and that consequently it could be used as a tumor biomarker. But 
while MGMT hypermethylation was also detected in various peripheral inflammatory diseases, it has not yet 
been investigated in non-neoplastic CNS diseases. 
Objectives: To investigate MGMT promoter methylation levels in various non-neoplastic CNS diseases. 
Methods: MGMT promoter methylation and expression levels of DNA demethylases TET1 and TET2 were inves-
tigated via pyrosequencing and immunohistochemistry on human autopsy or biopsy FFPE tissue samples with 
PML (10), MS (28), toxoplasmosis (6), CMV (1), HSV1 (1) or HIV (2) infection, mycotic encephalitis (4), brain ab-
scesses (3), central pontine / extrapontine myelinolysis (CPM/EPM) (8), Wallerian degeneration (3) and controls 
without CNS pathologies (8). 
Results: Slight MGMT hypermethylation was seen in non-neoplastic CNS diseases, all of which were associated 
with damaged myelin sheaths, i.e. inflammatory and demyelinating (MS and PML), as well as non-inflammatory 
metabolic or degenerative CNS diseases (CPM/EPM, Wallerian degeneration), while there were no associations 
with infectious non-demyelinating diseases or distinct pathogens. Reduced expression levels of TET1 could pos-
sibly be the cause for MGMT hypermethylation. 
Conclusion: MGMT hypermethylation is not restricted to neoplastic or infectious diseases but occurs in chronic 
CNS diseases that lead to damage of the myelin sheath in various ways. While this gives new insights into epige-
netic and pathophysiological processes involved in de-/remyelination, it also reduces the specificity of MGMT 
hypermethylation as a tumor biomarker. 
 
 
Meeting Abstract  





Copyright: © 2021 The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited, a link to the Creative Commons license is provided, and any changes are 




Free Neuropathol 2:22:31 
 
Chronic retrotransposon expression in mouse glial cells is associ-
ated with spatial learning deficits without an overt inflammatory 
response 
R. Sankowski1, G. Monaco1, M. Prinz1 
1 Universitätsklinikum Freiburg, Institut für Neuropathologie, Freiburg i. Br., Germany 
Introduction: Retrotransposons are mobile genomic elements comprising approximately 40 percent of the hu-
man and mouse genomes. Activation of retrotransposons has been associated with an inflammatory response in 
the brain and peripheral tissues. We have previously shown that chronic retrotransposon activation in B cell 
deficient mice was associated with astrogliosis and spatial learning deficits. 
Objective: We were wondering about cell-type dependent retrotransposon expression in the B cell deficient 
mouse model of constitutive retrotransposon activation. 
Materials & Methods: Here, we have utilised single-nucleus and single-cell RNA-Sequencing to profile the ex-
pression of retrotransposons in hippocampi and cortices of B cell deficient mice. 
Results: We could identify increased expression of long-terminal repeat and non-long terminal repeat retrotrans-
posons in microglia and astrocytes compared to other cell types. Surprisingly, these expression changes were not 
associated with an increased expression of genes encoding inflammatory mediators. We confirmed these results 
using bulk RNA sequencing. 
Conclusion: Our findings underscore the ability of brain tissues to attenuate an inflammatory response despite 
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DNA methylation-based classification of sinonasal tumors 
P. Jurmeister1, S. Glöß2, R. Roller3, S. Schmid2, R. Fritz3, A. Thieme2, C. Friedrich3, I. Hoffmann3, M. 
Leitheiser3, P. Mertins4, F. Klauschen1, D. Capper2 
1 Ludwig-Maximilians-University Munich, Institute of Pathology, München, Germany 
2 Charité – Universitätsmedizin Berlin, Department of Neuropathology, Berlin, Germany 
3 Charité – Universitätsmedizin Berlin, Institute of Pathology, Berlin, Germany 
4 Max-Delbrück-Centrum für Molekulare Medizin, Berlin, Germany 
 
Introduction: The histopathological diagnosis of sinonasal tumors is challenging as it encompasses a hetero-
genous spectrum of diverse differential diagnoses as well as poorly defined, disputed entities such as sinonasal 
undifferentiated carcinomas (SNUCs). 
Objectives: In this study, we aimed to develop a DNA methylation-based classification algorithm for sinonasal 
tumors and to elucidate the molecular background of SNUCs. 
Materials & Methods: We established a cohort of DNA methylation profiles from 374 sinonasal tumor speci-
mens, covering 17 tumor entities and normal control tissue. Furthermore, we performed DNA sequencing and 
mass spectrometry-based proteomics of selected cases. 
Results: A machine learning algorithm was able to reliably classifiy sinonasal tumors based on their DNA meth-
ylation profiles with clinical-grade accuracy. We further showed that tumors with SNUC morphology can be as-
signed to four molecular classes defined by distinct epigenetic, mutational and proteomic profiles. This included 
two classes with clear neuroendocrine differentiation in proteomics analysis which were characterized by either 
IDH2 mutations or SWI/SNF chromatin remodeling complex (SMARCA4/ARID1A) mutations and overall favorable 
clinical course. The third group comprised highly aggressive tumors, driven by SMARCB1-deficiency. The fourth 
SNUC class contained tumors that actually represented previously misclassified adenoid-cystic carcinomas, which 
was supported by recurrent MYB translocations and the resemeblance of these specimens with serous cell of 
submucosal glands in proteomics analysis. 
Conclusions: Our DNA methylation-based machine learning algorithm could greatly improve the diagnostics of 
challenging sinonasal tumors. Furthermore, we provide solid proof that sinonasal tumors are not as undifferen-
tiated as their current terminology implies, but rather represent distinct molecular groups with at least two clas-
ses showing clear neuroendocrine differentiation. 
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Deep Learning aided mitotic figure count in human meningiomas 
based on the open-source software SlideRunner 
S. Jabari1, C. Bertram2, R. Coras1, A. Maier3, I. Blümcke1, M. Aubreville4 
1 University Hospitals Erlangen, Institute for Neuropathology, Erlangen, Germany 
2 Veterinärmedizinische Universität Wien, Institut für Pathologie, Vienna, Austria 
3 Lehrstuhl für Mustererkennung, FAU, Erlangen, Germany 
4 Image Understanding and Medical Application of Artificial Intelligence, Ingolstadt, Germany 
Introduction: The World Health Organization (WHO) classification of brain tumors describes three grades of 
Meningioma: WHO I-III. A major factor that distinguishes the classes is the number of mitotic figures. Detecting 
and counting mitotic figures reliably in meningioma is, therefore, an essential part of the diagnostic workup.  
Objectives: However, detecting mitotic figures quickly, reliably, and comprehensively in a tissue section is a ma-
jor challenge. For this reason, we developed a technical assistance system that detects mitotic figures on whole-
slide-images and visualizes these as a heat map showing the mitotic density in almost real-time. 
Patients & methods: Meningioma samples were retrospectively collected from the Dept. of Neuropathology 
Erlangen, Germany. All samples were rereviewed by an expert neuropathologist and subsequently digitized using 
the Hamamatsu S60 digital slide scanner. The slides have been completely annotated for mitotic figures and we 
provide secondary annotations for mitotic figure look-alikes. Additionally to a blinded two-expert manual anno-
tation, we developed an algorithm-aided dataset, where potentially missed mitotic figures were detected by a 
deep neural network and subsequently assessed by a human expert. 
We used a pretrained deep-neuronal network approach (RetinaNet) to validate our data set. 
Finally, a plugin for SlideRunner, an open-source software, was built for convenience enabling real-time identifi-
cation of mitotic figures in virtual slides. 
Results: Out of 69 whole slide images of the complete data set, 46 were randomly assigned to the training set 
and 23 to be the test set. A preliminary evaluation yielded an F1 score of 0.659. 
Conclusion: Error-prone and tedious mitotic figure counts and region of interest identification may be assisted 
in the future with the help of modern deep learning algorithms integrated into a user-friendly software suite. 
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Intracranial Ependymoma in Adults, a Methylome-based Analysis 
M. Träger1, L. Schweizer2,3, P. Vajkoczy4, K. Fukuoka5, K. Ichimura5, U. Schüller6, L. Dührsen7, M. Müther8, 
W. Paulus9, C. Thomas9, J. Schittenhelm10, F. Eckert11, K. M. Niyazi12, D. F. Fleischmann12, M. Dorostkar13, 
P. Feyer14, S. A. May15, D. Moskopp16, H. Badakhshi17, S. Wecker17, C. Radke18, J. Walter19, D. Capper2,3, D. 
Kaul1,3 
1 Charité – Universitätsmedizin Berlin, Department of Radiation Oncology, Berlin, Germany 
2 Charité – Universitätsmedizin Berlin, Department of Neuropathology, Berlin, Germany 
3 German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Ger-
many 
4 Charité – Universitätsmedizin Berlin, Department of Neurosurgery, Berlin, Germany 
5 National Cancer Center Research Institute, Division of Brain Tumor Translational Research, Tokyo, Japan 
6 University Medical Center Hamburg-Eppendorf, Institute of Neuropathology, Hamburg, Germany 
7 University Medical Center Hamburg-Eppendorf, Department of Neurosurgery, Hamburg, Germany 
8 University Hospital Münster, Department of Neurosurgery, Münster, Germany 
9 University Hospital Münster, Institute of Neuropathology, Münster, Germany 
10 University Hospital Tübingen, Department of Neuropathology, Tübingen, Germany 
11 University Hospital Tübingen, Department of Radiation Oncology, Tübingen, Germany 
12 University Hospital, LMU Munich, Department of Radiation Oncology, München, Germany 
13 Ludwig-Maximilians-University Munich, Center for Neuropathology, München, Germany 
14 Vivantes Hospital Neukölln, Berlin, Germany 
15 Klinikum Chemnitz, Department of Neurosurgery, Chemnitz, Germany 
16 Vivantes Klinikum Im Friedrichshain, Department of Neurosurgery, Berlin, Germany 
17 Ernst Von Bergmann Medical Center, Academic Teaching Hospital of Humboldt University Berlin (Charité), De-
partment of Clinical Radiation Oncology, Potsdam, Germany 
18 Ernst Von Bergmann Medical Center, Academic Teaching Hospital of Humboldt University Berlin (Charité), De-
partment of Pathology, Potsdam, Germany 
19 Medical Center Saarbruecken, Department of Neurosurgery, Saarbrücken, Germany 
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Introduction: Recently DNA methylation profiling became widely accepted as a method to identify biologically 
distinct subgroups of ependymoma. However, due to the rarity of these tumors in adults, previous studies have 
failed to achieve a sufficient number of patients to characterize the landscape of DNA methylation profiles, their 
clinical characteristics and prognosis in this age group. 
Objectives: We investigated DNA methylation profiles of adult intracranial ependymoma collected from 12 dif-
ferent centers and sought to correlate molecular subgroups to clinical characteristics and outcome. 
Materials and methods: Tumors from 157 adult patients histologically classified as WHO grade II or III intracranial 
ependymoma between 1990 and 2020 were subjected to DNA methylation profiling using the Illumina Human 
Methylation 450k or EPIC Bead Chip platform. Profiles were matched with the DKFZ Brain Tumor Classifier and 
detected molecular subgroups were correlated with overall survival (OS) and progression free-survival (PFS). 
Results: In 68.8% (108/157) of cases, the suggested methylation class confirmed diagnosis of an ependymal tu-
mor with the additional assignment of a molecular subgroup (49 PFB, 36 SE, 17 RELA, 3 PFA, 2 spinal EPN and1 
myxopapillary EPN) whereas 5.7% (9/157) were not compatible with the initial diagnosis of ependymoma. The 
remaining 25.5% (40/157) did not reach a calibrated score ≥0.9 and were considered not classifiable. 
Median follow-up was 54 months. Five and 10-year PFS rates were 54.1% and 40.6% for SE, 65.2% and 37.1% for 
PF-B, 49% and 49% for RELA tumors. 
The 5- and 10-year OS rates were 70.1% and 49.1%for SE, 95.4% and 85.5% for PF-B and 100% and 75% for RELA 
tumors. 
Conclusion: This cohort of adult intracranial ependymoma comprises various molecular subgroups and even dif-
ferent tumor entities. Most patients with ependymal tumors confirmed by DNA methylation profiling show a 
favorable prognosis. However, factors that affect survival need to be determined. 
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Imaging of extended tissue areas by automated large-scale elec-
tron microscopy 
C. Dittmayer1, H. H. Goebel1,2, F. L. Heppner1, W. Stenzel1 
1 Charité – Universitätsmedizin Berlin, Department of Neuropathology, Berlin, Germany 
2 Johannes-Guttenberg Universität, Department of Neuropathology, Mainz, Germany 
Introduction: Traditional imaging of sections in diagnostic or research settings using transmission electron mi-
croscopy (TEM) is limited by manual acquisition procedures. Thus, analysis of samples is restricted to images of 
few preselected regions that may be non-representative and lack correlation to their microanatomical context. 
Modern scanning electron microscopes allow unbiased digitization of entire large sections and improved analy-
sis, but performance is limited by preparation artifacts. 
Objectives: We aimed at an improved preparation of sections for large-scale electron microscopy (EM) and at a 
pipeline for data processing and analysis. 
Material & methods: We achieved wrinkle-free collection of sections by a combined glow-discharge and ethanol-
based smoothening procedure and reduced filming and staining artifacts. A scanning electron microscope with 
a scanning transmission electron microscopy detector was used for pre-irradiation and imaging. Imaging param-
eters were varied to achieve fast imaging and adequate image quality. We used TrakEM2 and nip2 for stitching 
of image tiles to generate coherent bigtif datasets, thus allowing in-depth analysis via QuPath. 
Results: Our preparation workflow allowed to reliably prepare samples with virtual absence of limiting artifacts, 
such wrinkles and stain precipitates. Up to 12 entire sections were automatically digitized in about 6 days using 
7.3 nm pixel size and 1.0 µs dwell time. Our data processing pipeline allowed batch generation of bigtif files with 
minimal operator involvement. 
Conclusion: We propose a highly reliable workflow for preparation, imaging and data processing of samples with 
superior quality to enable routine large-scale EM in diagnostic and research settings. 
We demonstrate the high pragmatic value of our workflow with data of different published and unpublished 
projects in the field of muscle pathology and ultrastructural characterization of SARS-CoV-2 in autopsy tissues.  
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NanoString technology distinguishes anti-TIF-1γ+ from anti-Mi-
2+ Dermatomyositis patients 
C. Preuße1,2, P. Eede1, L. Heinzeling3,4, K. Freitag1,5, R. Koll1,6, W. Froehlich3, U. Schneider7, Y. Allenbach8, 
O. Benveniste8, A. Schänzer9, H. H. Goebel1, W. Stenzel1, J. Radke1,6 
1 Charité – Universitätsmedizin Berlin, Neuropathology, Berlin, Germany 
2 Münster University Hospital, Neurology with Institute for Translational Neurology, Münster, Germany 
3 University Hospital of Erlangen, Dermatology, Erlangen, Germany 
4 LMU Klinikum, Dermatology, München, Germany 
5 German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, Berlin, Germany 
6 German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Berlin, Germany 
7 Charité – Universitätsmedizin Berlin, Rheumatology, Berlin, Germany 
8 Pitié-Salpêtrière University Hospital, Internal Medicine and Clinical Immunology, Paris, France 
9 Justus-Liebig-University Gießen, Neuropathology, Gießen, Germany 
 
Introduction: Dermatomyositis (DM) is a systemic idiopathic inflammatory disease affecting skeletal muscle and 
skin, clinically characterized by symmetrical proximal muscle weakness and typical skin lesions. Recently, myo-
sitis-specific autoantibodies (MSA) became of utmost importance because they strongly correlate with distinct 
clinical manifestations and prognosis. Antibodies against transcription intermediary factor 1γ (TIF-1γ) are fre-
quently associated with increased risk of malignancy, a specific cutaneous phenotype and limited response to 
therapy in adult DM patients. Anti-Mi-2 autoantibodies, in contrast, are typically associated with classic DM 
rashes, prominent skeletal muscle weakness, better therapeutic response and prognosis, and less frequently 
with cancer. The correlation of cancer and Mi-2 autoantibodies, however, remains debated. 
Objectives: To further investigate the both clinically distinct DM subgroups and visualize differences or similari-
ties on gene and protein level. 
Patients & methods: We analyzed 30 DM patients (n=15 Mi2+ and n=15 TIF-1γ+) and 8 non-disease controls 
(NDC) by NanoString, qPCR, and immunohistochmistry. 
Results: Both anti-TIF-1γ+ and anti-Mi-2+ patients" skeletal muscle biopsies revealed strong dysregulation of 
immune response-related genes compared to NDCs. In line with previous reports, these included well-known 
type 1 IFN-inducible genes; however, we also identified subgroup-specific differences. 
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Conclusion: Our results help to stratify both subgroups and predict, which DM patients require an intensified 
diagnostic procedure and might have a poorer outcome. Additionally, we demonstrate that the NanoString tech-
nology can be used as a very sensitive method to clearly differentiate two clinically distinct DM subgroups, 
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Immunomodulatory function of GM-CSF in idiopathic inflamma-
tory myopathies 
D. Cengiz1,2, T. Müntefering2, J. Schubert1, C. Preuße3, W. Stenzel3, S. Meuth2, T. Ruck2 
1 Clinic for Neurology with Institute for Translational Neurology, University Hospital, Münster, Germany 
2 Heinrich-Heine University Düsseldorf, Department of Neurology, Medical Faculty, Düsseldorf, Germany 
3 Charité Universitätsmedizin, Department of Neuropathology, Berlin, Germany 
Introduction: Idiopathic inflammatory myopathies (IIMs) are characterized by chronic inflammation of the mus-
cle, resulting in muscle weakness and pain. Pathogenesis is driven by the interaction of skeletal muscle, muscle 
endothelial and immune cells. Cytokines play a central role in controlling these interactions. GM-CSF is a cytokine, 
which is significantly involved in the development of autoimmune diseases and is currently being investigated in 
clinical trials for therapy.  
Objectives: The role of GM-CSF in the inflammatory processes of IIMs is largely unknown. Therefore, the aim of 
this work is to investigate its immunomodulatory function. 
Materials & Methods: Murine skeletal muscle and endothelial cells were stimulated with GM-CSF and other pro- 
and anti-inflammatory cytokines. To analyze the impact of these conditions, flow cytometric analysis was per-
formed. Furthermore, the immunological relevance of GM-CSF on immune cell migration and adhesion were 
investigated. The expression of GM-CSF was also evaluated in human muscle biopsies of IIM patients. 
Results: Stimulation with pro- and anti-inflammatory cytokines regulate the expression of GM-CSF and the GM-
CSF receptor in muscle and endothelial cells. GM-CSF led to increased expression of costimulatory molecules on 
skeletal muscle cells, as well as decreased expression of adhesion molecules on endothelial cells. Stimulation also 
resulted in increased immune cell migration across muscle endothelial barriers. In human muscle biopsies of IIM 
patients, histological analysis revealed high expression of GM-CSF. 
Conclusion: The GM-CSF signaling pathway affects the cellular interactions of muscle, endothelial, and immune 
cells in the skeletal muscle. These findings could contribute to elucidate autoimmune processes in IIMs and iden-
tify new therapeutic targets. 
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Effect of vasoactive therapy in patients with Systemic Sclerosis on 
dermal small nerve fibers, Langerhans-cells and vessel density. 
L. Bajors1, F. Höcketstaller2, M. Köhm2,3, S. Seidel4, R. Wolf5, A. Roth1, U. Drott2,6, A. Schänzer1 
1 Justus-Liebig-University Gießen, Institute of Neuropathology, Gießen, Germany 
2 Goethe University Frankfurt, Department of Rheumatology, Frankfurt a. M., Germany 
3 Goethe University Frankfurt, Fraunhofer Project Group Translational Medicine and Pharmacology, IME, Frankfurt 
a. M., Germany 
4 Goethe University Frankfurt, Institute of Cell Biology and Neuroscience and Buchmann Institute for Molecular Life 
Sciences (BMLS), Frankfurt a. M., Germany 
5 Philipps University Marburg, Department of Dermatology and Allergology, Marburg, Germany 
6 MEDIAN Klinik Schlangenbad, Department of Rheumatology, Wiesbaden, Germany 
 
Introduction: Systemic Sclerosis (SSc) is an orphan immune-mediated disease affecting multiple organ systems. 
Most commonly, clinical symptoms such as skin fibrosis and digital ulceration occur early in disease course. Here, 
vasculopathy is an underlying aetiology. Additional, small nerve fibers (SNF) might be affected in in SSc patients 
and contribute to disease progression. 
Material and Methods: 21 SSc patients received intravenous medication iloprost for 10 days (95% females; 
56,1±11,9 years). 7 healthy subjects served as controls (71% f; 51,6±18,3 y). Skin biopsies were taken from the 
volar forearm before and 3 months after treatment. Epidermal nerve density (END), Langerhans cells (LC) and 
vessel density (VD) were analysed at immunofluorescence-stained sections using a Zeiss AxioScanner and imageJ 
software. The skin pathology was categorized with a histological skin score. 
Results: The SSc group showed no significant difference of END and LC density (13,09±4,26 SNF/mm; 259,8±121,5 
LC/mm²) compared to controls (10,8±3,11 SFN/mm, p=0,198; 335,4±124,86 LC/mm², p=0,091) or after treatment 
(12,71±5,82 SNF/mm, p=0,49; 305,4±98,5 LC/mm², p=0,098). The VD was significantly increased in the SSc group 
compared to controls (3,01±1,10µm²/100µm²; 2,18±1,12µm²/100µm²; p=0,046). In the SSc group, the VD was 
significantly decreased after treatment (2,51±0,78µm²/100µm²; p=0,044). The histological skin score showed 
overall low fibrotic alterations in both groups. 
Conclusion: In our study, SSc patients showed a higher VD compared to controls and VD was affected during 
short-term iloprost-therapy. Megacapillaries is a key feature of SSc and the results should be correlated with 
results of capillary microscopy. END and LC were not altered during treatment in SSC patients. Maybe these 
findings depend on the low skin score showed in the patients. To investigate further correlations, the results will 
be correlated with clinical parameters. 
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The interplay between neuroimmune activation and blood brain 
barrier dysfunction in Alzheimer's disease 
M. Armbrust1, A. Dominguez-Belloso1, R. Figueiredo2, K. Gneiding1, S. Guérit1, S. Thom1, P. Winter2, K. H. 
Plate1, P. N. Harter1, K. Devraj1, S. Liebner1 
1 Goethe University Hospital, Neurological Institute, Edinger Institute, Frankfurt a. M., Germany 
2 GenXPro GmbH, Frankfurt a. M., Germany 
Introduction: Alzheimer's disease (AD) is characterized by amyloid-β aggregation, hyperphosphorylated tau pro-
tein, neuroimmune activation, neuronal loss and blood brain barrier (BBB) dysfunction. The contribution of the 
latter to disease genesis and progression is poorly understood.  
Objectives: To investigate Wnt/β-catenin and BBB-specific alterations in AD. 
Materials and Methods: Transgenic mice harbouring triple-mutated (SwDI) human APP were used for 3'-RNA-
sequencing (Massive Analysis of cDNA Ends: MACE) of isolated mouse brain microvessels (MBMVs) and of FACS-
sorted cells of the neurovascular unit (endothelial cells (ECs), mural cells, astrocytes and microglia (MG)). An 
activation of the Wnt/β-catenin pathway in ECs was conducted in a Cre-LoxP-based β-catenin gain-of-function 
(GOF)-AD mouse model. Tracer permeability assays, immunohistochemistry and immunofluorescence analyses 
as well as behavourial tests were performed in AD and AD-GOF mice. 
Results: Gene Ontology analysis revealed a downregulation of Wnt/β-catenin signalling in MBMVs and FACS-
sorted ECs of AD mice. Dkk2, encoding Dickkopf Wnt pathway inhibitor 2, was upregulated in MBMVs and MG. 
In human AD brain tissue, DKK2 was detected in MG. Additionally, an increase in BBB permeability correlating 
with cognitive decline and a decrease of vascular lymphoid enhancer-binding factor 1 expression, a target and 
key player in Wnt/β-catenin signalling, was observed in AD mice. A presymptomatic activation of the Wnt/β-
catenin pathway in ECs of GOF-AD mice partially prevented cognitive decline. 
Conclusion: DKK2 upregulation in microvessel-associated MG could contribute to the Wnt/β-catenin pathway 
repression observed at the BBB in AD. Together with the prevention of cognitive decline after presymptomatic 
activation of the Wnt/β-catenin pathway, our findings indicate a potential link between neuroimmune activation 
and BBB dysfunction and propose the Wnt/β-catenin pathway as a potential therapeutic target. 
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A deep learning approach for monitoring parietal-dominant Alz-
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Amyloid-β dimers (Aβ-S8C) are antiprions inhibiting seeded nu-
cleation in vivo 
E. van Gerresheim1, A. Müller-Schiffmann1, S. Schäble2, C. Korth1 
1 Heinrich-Heine University Düsseldorf, Neuropathology, Düsseldorf, Germany 
2 Heinrich-Heine University Düsseldorf, Experimental Psychology, Düsseldorf, Germany 
Introduction: Alzheimer"s disease (AD) is a neurologic disorder, were amyloid-beta (Aβ) aggregation causes mas-
sive neuronal death. Aβ expansion can follow prion-like replication from Aβ seeds. With the current animal mod-
els, based on the overexpression of Aβ, used to study the Aβ cascade and prion-like expansion, it is impossible 
to distinguish between exogenous de novo seeding and accelerated spontaneous plaque development. So far, 
seeding of Aβ in wild type animals has not been successful. 
Objectives: Here we studied the effects of Aβ-S8C dimers on Aβ prion spreading and induced behavioral changes. 
Materials and Methods: TgDimer mice, expressing human APP751 (Swe, K670 N/ M671L, S679C), only develop 
Aβ-S8C dimers and do not develop Aβ plaques, but do associate to existing plaques, were crossed with Gfap-luc 
mice, enabling bioluminescence (BLI) monitoring of Aβ aggregation-associated astrogliosis. Mice were intra-hip-
pocampal inoculated with Aβ aggregates. Wild type and APP23 mice, Aβ aggregate inoculated, were used as 
controls. Cognition was probed in the observer-free paradigm, the CognitionWall, for reward-dependent learning 
and burrowing as species-specific behavior. 
Results: We observed no Aβ aggregation-associated astrogliosis or impaired cognition in the tgDimer mice inoc-
ulated with Aβ aggregate. For the positive control, the APP23 mice, an increase in BLI signal started at 11 months 
of age and at 18 months of age, APP23 mice showed impaired discrimination learning in the CognitionWall. 
Conclusions: Aβ-S8C dimers inhibit Aβ aggregate spreading and are thus anti-prions. They may have a regulatory 
role for aggregate spreading suggesting that Aβ prion effects are actively regulated rather than a passive process. 
The difference in time of start of Aβ aggregate spreading and impaired discrimination learning in APP23 mice 
suggests that behavioral consequences are disparate from initial neuropathological signs. 
 
 
Meeting Abstract  





Copyright: © 2021 The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited, a link to the Creative Commons license is provided, and any changes are 




Free Neuropathol 2:22:45 
 
A decline in peroxisomal numerical abundance occurs late during 
Alzheimer´s disease progression and is particulary found in the 
hippocampus 
E. Semikasev1, B. Ahlemeyer1, T. Acker2, A. Schänzer2, E. Baumgart-Vogt1 
1 Institute of Anatomy and Cell Biology, Medical Cell Biology, JL University, Gießen, Germany 
2 Institute of Neuropathology, JL University, Gießen, Germany  
Peroxisomal biogenesis disorders are inherited metabolic diseases caused by mutations in the PEX genes. In se-
vere forms, patients have profound defects in the brain demonstrating the importance of this organelle for neu-
ronal survival and function. Additionally, dysfunction of the peroxisomal metabolism, e.g. plasmalogen synthesis 
or the degradation of very long-chained fatty acids, has to been linked to neurodegenerative diseases such as 
Alzheimer´s disease (AD). 
To study the role of peroxisomes in AD, we analyzed the density of this organelle in the perikarya of pyramidal 
cells in the hippocampus (cornu ammonis, subiculum and the entorhinal cortex layer III) as well as neocortical 
regions (frontal, temporal, parietal und occipital) of brain from patients with different neuropathological stages. 
We used double immunofluorescence staining techniques to detect PEX14 (as marker for the total peroxisome 
numerical abundance) and β-amlyoid plaques or neurofibrillary tangles (NFTs)s in different brain regions. Human 
brains were gender- and age-matched and classified into 5 patient groups based to the ABC-Score. All 42 brain 
samples were from the Institute of Neuropathology in Gießen. Quantification of peroxisome number per area 
(density) was performed by ImageJ free software. 
With ongoing stages of AD, we measured a progressive decline in the density of peroxisomes in pyramidal cells 
of all hippocampal and neocortical areas. The effect was even more pronounced when we included known AD 
risk factors such as vascular angiopathies. Interestingly, the decrease in the density of peroxisomes at late stages 
in AD was more evident in patients ≤80 years old than in patients >81 years old. However, we did not find a 
correlation between the intraneuronal peroxisome density and the amount of β-amyloid and NFTs. 
Our data suggest that peroxisomes may play a protective role in AD and their decline in numerical density – 
especially in the hippocampus – occurs late during AD progression. 
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Its not all about Covid19 - Incidental finding of hereditary Neu-
roferritinopathy in a 78-year-old woman diagnosed with COVID-
19 associated pneumonia 
V. Umathum1,2, D. Amsel1, A. Weber3, C. Becker4, C. Kasan4, A. May5, T. Acker1, A. Schänzer1 
1 Justus-Liebig-University Gießen, Institute of Neuropathology, Gießen, Germany 
2 Bundeswehrkrankenhaus Ulm, Institute of Pathology and Molecular Pathology, Ulm, Germany 
3 Justus-Liebig-University Gießen, Institute of Human Genetics, Gießen, Germany 
4 Institute of Pathology, Cytology and Molecular Pathology, Wetzlar, Germany 
5 Agaplesion Evangelisches Krankenhaus, Department of Pulmonology, Gießen, Germany 
Introduction: Neuroferritinopathy (NF) is an autosomal-dominant movement disorder due to mutations in the 
L-ferritin gene (FTL) on chromosome 19q13.33. NF belongs to neurodegeneration with brain iron accumulation 
(NBIA) disorders, a group of hereditary neurodegenerative diseases with a prevalence of 1/1.000.000.  Patients 
with NF present clinically with progressive extrapyramidal movement symptoms with variable phenotype. Histo-
pathologically, NF is characterized by iron deposits and formation of ferritin inclusion bodies (IBs).  
Clinical History: A 78-year-old woman was hospitalized with a severe Covid-19 pneumonia and after three 
months died from Covid19-associated pneumonia. During her 3-month clinical course she showed neurological 
symptoms of delirium and restlessness. Cranial MRI was not performed. 
Neuropathological Findings: Brain weight was 1172 g. No abnormalities were seen in cross sections. Histological 
examination revealed frequent atypical iron accumulation throughout the brain particularly in the basal ganglia. 
The nuclear spherical iron inclusions were localized in neurons, microglia and oligodendrocytes stained for Prus-
sian blue and immunohistochemically with antibodies against Anti-Ferritin Light Chain. Electron microscopy 
showed fragmented nuclei with inclusions and chromatin accumulation toward the membrane consistent with 
IBs. Moderate microcystic vacuolization and partial loss of myelination of nerve fibres were evident. 
Discussion and Conclusion:131 cases of NF have been described so far in the literature with 80% in France and 
the UK and 20% throughout the world. Movement disorders or cognitive impairments were not reported in our 
patient, maybe due to a lack of full penetrance that occurs at the age of 60, in general. In our patient, the brain 
pathology is suspicious for a NF. Most of the patients harbour an adenine insertion at position 460-461 of the 
FTL-Gene. Whole exome sequencing from brain tissue is in progress to confirm the diagnosis. 
 
 
Meeting Abstract  





Copyright: © 2021 The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited, a link to the Creative Commons license is provided, and any changes are 




Free Neuropathol 2:22:47 
 
Role of purinergic receptor P2Y12 in Alzheimer's disease 
R. Maruccia1,2, A. A. Gabr1, M. J. Pietrowski1, B. A. Tambe1, A. Halle1,2 
1 Deutsches Zentrum für Neurodegenerative Erkrankungen, Bonn, Germany 
2 Universitätsklinikum Bonn, Institut für Neuropathologie, Bonn, Germany 
Microglia have recently moved into prime focus of AD research due to the discovery of risk loci and genes that 
are linked to immune mechanisms, some of them highly expressed in microglia. However, immune signaling 
pathways in microglia that modulate AD progression, for example by removing Aβ plaques, have remained poorly 
understood. 
The purinergic receptor P2Y12 is activated by extracellular ATP and ADP and is highly expressed in platelets and 
microglia. P2Y12 is crucial for several microglial functions such as chemotaxis, blood-brain barrier closure, syn-
aptic plasticity, interaction with neuronal somata and phagocytosis. Thus, a compromised microglial phagocytic 
removal of Aβ and impaired plaque barrier formation upon P2Y12 deletion may affect AD progression. 
Here we analyze 3D-reconstructed confocal images of brain tissue from AD models to assess the role of P2Y12 in 
the progression of Aβ pathology, microglia-plaque interaction and inter-cellular interaction between microglial 
cells under neurodegenerative conditions. 
Our preliminary findings suggest a region-dependent modulation of microglial coverage and co-localization with 
plaques in models with P2Y12 deletion and therefore that this receptor may affect microglial interaction with Aβ 
plaques.  
Future studies investigating plaque load changes and the interplay between microglia, astrocytes and neurons 
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